(SLAB) Silicon Laboratories - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8269191024
Stock:
Total Rating 63
Risk 93
Buy Signal 0.51
| Risk 5d forecast | |
|---|---|
| Volatility | 47.6% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 8.21 |
| Character TTM | |
|---|---|
| Beta | 1.689 |
| Beta Downside | 2.924 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.43% |
| CAGR/Max DD | 0.09 |
EPS (Earnings per Share)
Revenue
Description: SLAB Silicon Laboratories
Silicon Laboratories Inc., a fabless semiconductor company, provides mixed-signal analog intensive products in the United States, China, Taiwan, and internationally. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including connected home and security, industrial automation and control, smart metering and agriculture, smart street lighting, renewable energy, electric vehicle supply equipment, industrial wearables and equipment, commercial building automation, consumer electronics, asset tracking, and medical instrumentation; and commercial IoT applications, including smart buildings and lighting, access controls, asset tracking, electronic shelf labels, theft protection, power tools, and enterprise access points. The company's smart home applications comprise smart home cameras, locks, gateways, residential lighting, window shades/blinds, heating, ventilation, air conditioning, switches, smoke/CO detectors, sensors, and home security panels; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking, as well as provides wireless microcontrollers products. It sells its products through its direct sales force, as well as a network of independent sales representatives and distributors. The company was founded in 1996 and is headquartered in Austin, Texas.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -64.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 7.28 > 1.0 |
| NWC/Revenue: 67.57% < 20% (prev 86.27%; Δ -18.70% < -1%) |
| CFO/TA 0.08 > 3% & CFO 95.7m > Net Income -64.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.9m) vs 12m ago 1.54% < -2% |
| Gross Margin: 58.23% > 18% (prev 0.53%; Δ 5770 % > 0.5%) |
| Asset Turnover: 62.98% > 50% (prev 47.80%; Δ 15.19% > 0%) |
| Interest Coverage Ratio: -58.63 > 6 (EBITDA TTM -19.1m / Interest Expense TTM 975.0k) |
Altman Z'' 10.00
| A: 0.42 (Total Current Assets 674.0m - Total Current Liabilities 143.8m) / Total Assets 1.27b |
| B: 0.74 (Retained Earnings 936.8m / Total Assets 1.27b) |
| C: -0.05 (EBIT TTM -57.2m / Avg Total Assets 1.25b) |
| D: 5.36 (Book Value of Equity 937.0m / Total Liabilities 174.9m) |
| Altman-Z'' Score: 10.46 = AAA |
Beneish M -3.13
| DSRI: 0.88 (Receivables 64.5m/54.5m, Revenue 784.8m/584.4m) |
| GMI: 0.92 (GM 58.23% / 53.42%) |
| AQI: 0.92 (AQ_t 0.37 / AQ_t-1 0.40) |
| SGI: 1.34 (Revenue 784.8m / 584.4m) |
| TATA: -0.13 (NI -64.9m - CFO 95.7m) / TA 1.27b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of SLAB shares?
As of February 26, 2026, the stock is trading at USD 204.16 with a total of 569,487 shares traded.
Over the past week, the price has changed by -0.63%, over one month by +45.20%, over three months by +65.31% and over the past year by +41.49%.
Over the past week, the price has changed by -0.63%, over one month by +45.20%, over three months by +65.31% and over the past year by +41.49%.
Is SLAB a buy, sell or hold?
Silicon Laboratories has received a consensus analysts rating of 3.73.
Therefor, it is recommend to hold SLAB.
- StrongBuy: 3
- Buy: 2
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SLAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 222.9 | 9.2% |
| Analysts Target Price | 222.9 | 9.2% |
SLAB Fundamental Data Overview February 21, 2026
P/E Forward = 76.3359
P/S = 8.6001
P/B = 6.2421
P/EG = 3.0343
Revenue TTM = 784.8m USD
EBIT TTM = -57.2m USD
EBITDA TTM = -19.1m USD
Long Term Debt = 24.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -364.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.38b USD (6.75b + (null Debt) - CCE 364.2m)
Interest Coverage Ratio = -58.63 (Ebit TTM -57.2m / Interest Expense TTM 975.0k)
EV/FCF = 97.05x (Enterprise Value 6.38b / FCF TTM 65.8m)
FCF Yield = 1.03% (FCF TTM 65.8m / Enterprise Value 6.38b)
FCF Margin = 8.38% (FCF TTM 65.8m / Revenue TTM 784.8m)
Net Margin = -8.27% (Net Income TTM -64.9m / Revenue TTM 784.8m)
Gross Margin = 58.23% ((Revenue TTM 784.8m - Cost of Revenue TTM 327.8m) / Revenue TTM)
Gross Margin QoQ = 63.44% (prev 57.78%)
Tobins Q-Ratio = 5.03 (Enterprise Value 6.38b / Total Assets 1.27b)
Interest Expense / Debt = unknown (Interest Expense 214.0k / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.2m (EBIT -57.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.69 (Total Current Assets 674.0m / Total Current Liabilities 143.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 19.09 (negative EBITDA) (Net Debt -364.2m / EBITDA -19.1m)
Debt / FCF = -5.54 (Net Debt -364.2m / FCF TTM 65.8m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.21% (Net Income -64.9m / Total Assets 1.27b)
RoE = -6.05% (Net Income TTM -64.9m / Total Stockholder Equity 1.07b)
RoCE = -5.21% (EBIT -57.2m / Capital Employed (Equity 1.07b + L.T.Debt 24.0m))
RoIC = -4.21% (negative operating profit) (NOPAT -45.2m / Invested Capital 1.07b)
WACC = 12.14% (E(6.75b)/V(6.75b) * Re(12.14%) + (debt-free company))
Discount Rate = 12.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.67%
[DCF] Terminal Value 54.14% ; FCFF base≈65.8m ; Y1≈43.2m ; Y5≈19.7m
[DCF] Fair Price = 17.99 (EV 228.5m - Net Debt -364.2m = Equity 592.8m / Shares 33.0m; r=12.14% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -51.69 | EPS CAGR: -15.43% | SUE: 0.13 | # QB: 0
Revenue Correlation: -35.41 | Revenue CAGR: -3.05% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=10
EPS current Year (2026-12-31): EPS=2.71 | Chg7d=+0.001 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+194.2% | Growth Revenue=+18.1%
EPS next Year (2027-12-31): EPS=4.14 | Chg7d=+0.112 | Chg30d=+0.114 | Revisions Net=+2 | Growth EPS=+53.1% | Growth Revenue=+16.3%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
P/S = 8.6001
P/B = 6.2421
P/EG = 3.0343
Revenue TTM = 784.8m USD
EBIT TTM = -57.2m USD
EBITDA TTM = -19.1m USD
Long Term Debt = 24.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -364.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.38b USD (6.75b + (null Debt) - CCE 364.2m)
Interest Coverage Ratio = -58.63 (Ebit TTM -57.2m / Interest Expense TTM 975.0k)
EV/FCF = 97.05x (Enterprise Value 6.38b / FCF TTM 65.8m)
FCF Yield = 1.03% (FCF TTM 65.8m / Enterprise Value 6.38b)
FCF Margin = 8.38% (FCF TTM 65.8m / Revenue TTM 784.8m)
Net Margin = -8.27% (Net Income TTM -64.9m / Revenue TTM 784.8m)
Gross Margin = 58.23% ((Revenue TTM 784.8m - Cost of Revenue TTM 327.8m) / Revenue TTM)
Gross Margin QoQ = 63.44% (prev 57.78%)
Tobins Q-Ratio = 5.03 (Enterprise Value 6.38b / Total Assets 1.27b)
Interest Expense / Debt = unknown (Interest Expense 214.0k / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.2m (EBIT -57.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.69 (Total Current Assets 674.0m / Total Current Liabilities 143.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 19.09 (negative EBITDA) (Net Debt -364.2m / EBITDA -19.1m)
Debt / FCF = -5.54 (Net Debt -364.2m / FCF TTM 65.8m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.21% (Net Income -64.9m / Total Assets 1.27b)
RoE = -6.05% (Net Income TTM -64.9m / Total Stockholder Equity 1.07b)
RoCE = -5.21% (EBIT -57.2m / Capital Employed (Equity 1.07b + L.T.Debt 24.0m))
RoIC = -4.21% (negative operating profit) (NOPAT -45.2m / Invested Capital 1.07b)
WACC = 12.14% (E(6.75b)/V(6.75b) * Re(12.14%) + (debt-free company))
Discount Rate = 12.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.67%
[DCF] Terminal Value 54.14% ; FCFF base≈65.8m ; Y1≈43.2m ; Y5≈19.7m
[DCF] Fair Price = 17.99 (EV 228.5m - Net Debt -364.2m = Equity 592.8m / Shares 33.0m; r=12.14% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -51.69 | EPS CAGR: -15.43% | SUE: 0.13 | # QB: 0
Revenue Correlation: -35.41 | Revenue CAGR: -3.05% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=10
EPS current Year (2026-12-31): EPS=2.71 | Chg7d=+0.001 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+194.2% | Growth Revenue=+18.1%
EPS next Year (2027-12-31): EPS=4.14 | Chg7d=+0.112 | Chg30d=+0.114 | Revisions Net=+2 | Growth EPS=+53.1% | Growth Revenue=+16.3%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)